Neoadjuvant Palbociclib on ER+ Breast Cancer (N007): Clinical Response and EndoPredict Value
Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-17-0396
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2018
Authors
Publisher
Bioscientifica